3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, D; Chen, J; He, B; Li, M; Liu, P; Meng, L; Zhang, X; Zhang, Y; Zhao, J | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Leukemia
Article | Year |
---|---|
The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Apoptosis; Benzoxazoles; Biological Transport; Calcium; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Leukemia; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Spectrometry, Fluorescence; Time Factors | 2009 |